Back to top
more

Veeva Systems (VEEV)

(Delayed Data from NYSE)

$204.67 USD

204.67
466,941

+0.14 (0.07%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $204.53 -0.14 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (68 out of 251)

Industry: Internet - Software

Better trading starts here.

Zacks News

Here's Why You Should Add Amedisys (AMED) to Your Portfolio

Amedisys (AMED) continues to see impressive performance by Personal Care business. The company's focus on improving clinical quality buoys optimism.

Varian Medical's (VAR) Halcyon Gets NMPA Approval in China

Varian Medical (VAR) enjoys significant international presence in radiotherapy.

Walgreens Gains from New Alliances, International Expansion

Walgreens Boots (WBA) is benefiting from strategic tie-ups. The Express Scripts and Kroger deals are intended to expand its existing group purchasing efforts and product offerings.

Veeva Systems (VEEV) Q3 Earnings & Revenues Beat Estimates

Veeva Systems' (VEEV) impressive Q3 results can be attributed to the Subscription Service segment's solid performance. An upbeat FY19 guidance instills investor optimism in the stock

Veeva Systems (VEEV) Q3 Earnings and Revenues Surpass Estimates

Veeva (VEEV) delivered earnings and revenue surprises of 18.42% and 3.93%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?

Integra's (IART) Margin Pressure Hurts, Global Prospects High

Massive gross margin declines induced by mounting costs are a major downside for Integra LifeSciences (IART).

PRA Health Launches PSN to Expand in Pediatric Care, Stock Up

PRA Health's (PRAH) Center for Pediatric Clinical Development is likely to enhance pediatric clinical testing and design with the latest move.

Here's Why You Should Buy Thermo Fisher (TMO) Stock Now

Thermo Fisher (TMO) gains on strength in all end markets. It witnesses consistent growth in the Asia-Pacific and emerging markets.

Cardinal Health to Highlight Cost-Control Approach in ASHP

Cardinal Health (CAH) helps hospitals identify hidden savings, improve patient outcomes and drive supply chain efficiencies.

Quest Diagnostics to Buy Laboratory Services Unit in Midwest

Quest Diagnostics (DGX) continues to expand inorganically. The latest buyout is expected to expand the company's portfolio in the Midwest.

CVS Health (CVS) Gets Final Approval to Close Aetna Deal

Both CVS Health (CVS) and Aetna are hopeful about this consolidation, which is aimed at revolutionizing consumer health care experience and substantial cost reduction.

Medtronic (MDT) Positive on Mazor Purchase, Rising Costs Ail

The pending acquisition of Mazor Robotics holds great potential as it is likely to solidify Medtronic's (MDT) position in robotic spine surgery.

Align Technology's New iTero Scanner Updates to Boost Uptake

Align Technology (ALGN) adopts initiatives to boost top-line contributions from iTero Intraoral scanners.

Here's Why Investors Should Hold Medidata (MDSO) Stock Now

Solid prospects in the Rave Genomics platform are likely to provide Medidata (MDSO) a competitive edge in the MedTech space.

Edwards Lifesciences' Critical Care Arm Solid, THVT View Dull

Edwards Lifesciences (EW) sees strong Critical Care division sales. Management expects sluggish underlying THVT sales for 2018.

PerkinElmer's Vanadis NIPT CE Mark Boosts Prenatal Prospects

PerkinElmer's (PKI) Vanadis NIPT is a more cost effective and non-invasive screening system compared to traditional ones.

Here's Why You Should Invest in Merit Medical (MMSI) Now

A strong outlook for 2018 and a solid global foothold make Merit Medical (MMSI) a promising investment pick.

Here's Why You Should Invest in Abiomed (ABMD) Right Now

Abiomed (ABMD) continues to gain from its flagship Impella; a strong fiscal 2019 outlook encourages.

Here's Why You Should Invest in Hill-Rom (HRC) Stock Now

Hill-Rom (HRC) focuses on product innovation. Through fiscal 2018, new products generated more than $300 million in revenues.

Medtronic's Deal With Nutrino Health to Boost Diabetes Arm

Bringing Nutrino under Medtronic's (MDT) Diabetes Group will help the acquirer speed up its growth in the same business.

Medtronic Gets Health Canada License for Visualase System

Medtronic (MDT) adopts initiatives to boost top-line contributions from the Brain Therapies arm.

Here's Why You Should Buy Intuitive Surgical (ISRG) Now

Strength in the surgical platform and an upbeat view for 2018 make Intuitive Surgical (ISRG) a promising pick.

Insulet's (PODD) Omnipod DASH System Now ISO 27001 Certified

Insulet (PODD) is now the only insulin pump company to be awarded with both the ISO 27001 and the DTSec Cybersecurity Standard for Connected Diabetes Device Security certifications.

Can Segmental Growth Boost Veeva Systems' (VEEV) Q3 Earnings?

Veeva Systems (VEEV) likely to gain from solid segmental show in fiscal Q3; competition stiff.

Veeva Systems (VEEV) Reports Next Week: Wall Street Expects Earnings Growth

Veeva (VEEV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.